RetractedReviewDisease markers2022

Research Progress of PI3K/PTEN/AKT Signaling Pathway Associated with Renal Cell Carcinoma.

Yakun Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.